Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$36.5 - $52.5 $3.65 Million - $5.25 Million
-100,001 Reduced 58.73%
70,269 $3.46 Million
Q4 2023

Feb 14, 2024

SELL
$18.94 - $37.24 $2.83 Million - $5.57 Million
-149,641 Reduced 46.78%
170,270 $6.21 Million
Q3 2023

Nov 14, 2023

BUY
$23.12 - $31.38 $168,452 - $228,634
7,286 Added 2.33%
319,911 $7.4 Million
Q2 2023

Aug 14, 2023

SELL
$23.15 - $32.71 $115,750 - $163,550
-5,000 Reduced 1.57%
312,625 $8.2 Million
Q1 2023

May 15, 2023

BUY
$24.97 - $34.05 $24,970 - $34,050
1,000 Added 0.32%
317,625 $8.18 Million
Q4 2022

Feb 14, 2023

BUY
$21.73 - $28.72 $325,950 - $430,800
15,000 Added 4.97%
316,625 $8.24 Million
Q3 2022

Nov 14, 2022

SELL
$24.1 - $39.66 $5.66 Million - $9.32 Million
-235,039 Reduced 43.8%
301,625 $8.61 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $1.41 Million - $4.6 Million
76,639 Added 16.66%
536,664 $13.2 Million
Q1 2022

May 16, 2022

BUY
$48.97 - $65.46 $5.75 Million - $7.69 Million
117,459 Added 34.29%
460,025 $26 Million
Q4 2021

Feb 14, 2022

BUY
$53.3 - $75.84 $5.04 Million - $7.18 Million
94,649 Added 38.18%
342,566 $21.2 Million
Q3 2021

Nov 15, 2021

BUY
$62.66 - $88.26 $3.31 Million - $4.66 Million
52,800 Added 27.06%
247,917 $15.7 Million
Q2 2021

Aug 17, 2021

BUY
$67.45 - $85.63 $3.87 Million - $4.92 Million
57,445 Added 41.73%
195,117 $16.1 Million
Q1 2021

May 17, 2021

BUY
$65.1 - $93.59 $6.92 Million - $9.96 Million
106,372 Added 339.85%
137,672 $10.1 Million
Q4 2020

Feb 16, 2021

BUY
$48.36 - $77.92 $1.51 Million - $2.44 Million
31,300 New
31,300 $2.27 Million
Q1 2020

May 14, 2020

SELL
$20.44 - $41.21 $4.09 Million - $8.24 Million
-200,000 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$17.74 - $39.52 $1.95 Million - $4.35 Million
-110,000 Reduced 35.48%
200,000 $7.7 Million
Q3 2019

Nov 14, 2019

BUY
$18.8 - $27.82 $5.83 Million - $8.62 Million
310,000 New
310,000 $6.72 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.